Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 9, 2026, 1:53 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 2041–2064 of 2,478 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Tissue Control Group Clear all

Conditions: Restless Legs Syndrome
Interventions: equal parts of 0.5% plain Marcaine and 2% lidocaine mixed with 0.8 mg Depo-medrol/4% absolute alcohol in a total injection volume of 1 ml, Normal saline - 1ml; Drug
Lead sponsor: Lowcountry Infectious Diseases; Other
Eligibility: 18 Years and older
Enrollment: 60 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2009
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Cirrhosis, Liver, End Stage Liver DIsease, Acute Kidney Injury, Liver Transplant; Complications
Interventions: Angiotensin II, Norepinephrine; Drug
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Pediatric Lumbar Puncture
Interventions: Normal Saline Intravenous Fluids; Other
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 0 Months to 3 Months
Enrollment: 182 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: Hyperglycemia, Hypoglycemia
Interventions: GLP 1, normal saline solution placebo; Biological
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2011
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Contrast-induced Nephropathy, Chronic Kidney Diseases
Interventions: Low-frequency therapeutic ultrasound (LOTUS), LOTUS System with Ultrasound Disabled; Device
Lead sponsor: Sonogenix; Industry
Eligibility: 18 Years and older
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 4
States / cities: Detroit, Michigan • Petoskey, Michigan • Pittsburgh, Pennsylvania + 1 more

Conditions: Bronchiolitis, Pneumonitis, Dyspnea
Interventions: Lung clearance index (LCI); Other
Lead sponsor: National Jewish Health; Other
Eligibility: 18 Years and older
Enrollment: 73 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2018
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Breast Cancer, Breast Implant; Complications, Infection or Inflammation
Interventions: Acellular Dermal Matrix, Reconstruction without ADM; Device · Procedure
Lead sponsor: University of California, Los Angeles; Other
Eligibility: 22 Years to 75 Years · Female only
Enrollment: 120 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2027
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Obesity, Insulin Resistance
Interventions: Mediterranean diet, Low-carbohydrate, ketogenic diet, Low-fat diet, Annual follow-up testing for 5 years; Behavioral · Other
Lead sponsor: Washington University School of Medicine; Other
Eligibility: 18 Years to 55 Years
Enrollment: 300 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2029
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Osteo Arthritis Knee
Interventions: Injection of Autologous Adipose Tissue, Injection of lactated ringers; Other
Lead sponsor: Aestique Medical Center; Other
Eligibility: 40 Years to 75 Years
Enrollment: 8 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2018
U.S. locations: 2
States / cities: Greensburg, Pennsylvania

Conditions: Smoking Cessation
Interventions: Delay time to first cigarette, Therapy; Behavioral
Lead sponsor: University of Kansas Medical Center; Other
Eligibility: 18 Years to 60 Years
Enrollment: 79 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2020
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Hypoxia
Interventions: Vasoconstrictor Agents, Head/neck repositioning, Increase ETCO2, IV fluid bolus, Additional anesthesia, RBC transfusion, Increase FiO2; Drug · Other · Biological
Lead sponsor: University Hospitals Cleveland Medical Center; Other
Eligibility: 65 Years and older
Enrollment: 74 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Hip Fractures
Interventions: Tranexamic Acid (TXA), Saline solution; Drug
Lead sponsor: Gregory M Georgiadis MD; Other
Eligibility: 60 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2027
U.S. locations: 1
States / cities: Toledo, Ohio

Conditions: Pulmonary Arterial Hypertension
Interventions: Coenzyme Q-10 in Pulmonary Hypertension subjects, Coenzyme Q-10 in Normal Control subjects; Dietary Supplement
Lead sponsor: The Cleveland Clinic; Other
Eligibility: 18 Years to 55 Years
Enrollment: 18 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Pain, Postoperative
Interventions: control group, treatment group; Drug
Lead sponsor: Mihaela Visoiu; Other
Eligibility: 8 Years to 17 Years
Enrollment: 84 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2010 – 2013
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Conditions: Hearing Loss, Sensorineural, Cognitive Impairment
Interventions: Auditory amplified, Visual, Auditory unamplified; Other
Lead sponsor: Northwestern University; Other
Eligibility: 60 Years to 85 Years
Enrollment: 37 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018
U.S. locations: 1
States / cities: Evanston, Illinois

Conditions: Healthy
Interventions: rLP2086, Placebo; Biological · Other
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years to 25 Years
Enrollment: 3,301 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2015
U.S. locations: 35
States / cities: Mobile, Alabama • Mesa, Arizona • Tempe, Arizona + 28 more

Conditions: Persistent Pulmonary Hypertension of the Newborn
Interventions: Not listed
Lead sponsor: Medical College of Wisconsin; Other
Eligibility: Up to 12 Months
Enrollment: 200 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2028
U.S. locations: 1
States / cities: Milwaukee, Wisconsin

Conditions: Glioblastoma Multiforme, Healthy Volunteers
Interventions: GBM Patients, Normal Controls; Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years to 89 Years
Enrollment: 130 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2013
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Dysbiosis
Interventions: Goya Foods - Canned Chickpeas, Goya Foods - Canned Lentils, Control; Other
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 30 Years
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Traumatic Brain Injury
Interventions: SDx3; Device
Lead sponsor: Sense Diagnostics, LLC; Industry
Eligibility: 22 Years to 50 Years
Enrollment: 75 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 2
States / cities: Atlanta, Georgia • Cincinnati, Ohio

Conditions: Alveolar Bone Resorption
Interventions: demineralized and mineralized combination putty bone allograft, calcium phosphosilicate putty alloplast graft; Biological
Lead sponsor: University of Louisville; Other
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Low Back Pain, Pregnancy
Interventions: Osteopathic Manipulative Treatment, Placebo Ultrasound; Other
Lead sponsor: University of North Texas Health Science Center; Other
Eligibility: 18 Years to 35 Years · Female only
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2011
U.S. locations: 1
States / cities: Fort Worth, Texas

Conditions: Cardiovascular Surgery, Pain, Postoperative, Block
Interventions: Liposomal bupivacaine, Normal Saline Flush, 0.9% Injectable Solution_#1; Drug
Lead sponsor: Baylor Research Institute; Other
Eligibility: 18 Years and older
Enrollment: 70 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Plano, Texas

Conditions: Laparoscopic Adnexal Surgery
Interventions: Normal Saline (0.9% NaCl), Marcaine hydrochloride without epinephrine 0.5%; Other · Drug
Lead sponsor: University of Tennessee; Other
Eligibility: 18 Years and older · Female only
Enrollment: 96 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2027
U.S. locations: 1
States / cities: Memphis, Tennessee

Search by objective public record fields.

Neuroma Injections to Treat Restless Legs Syndrome - RCT

Angiotensin 2 for AKI After OLT

Intravenous Fluid Administration's Effect on Pediatric Lumbar Puncture

GLP 1 for Intraoperative Glycemic Control

Multi-Center Trial Utilizing Low Frequency Ultrasound in the Prevention of Post-Contrast Acute Kidney Injury

Utility of Lung Clearance Index Score as a Noninvasive Marker of Deployment Lung Disease

Randomized Feasibility Trial for Mesh in Pre-Pectoral Reconstruction

Precision Nutrition and Metabolic Function

Injection of Autologous Adipose Tissue for Treatment of Osteoarthritis in the Knee

Neuroimaging Studies of Practice and Smoking

Cerebral Oximetry in Single Lung Ventilation Thoracic Surgery

Effect of Tranexamic Acid (TXA) on Reduction of Postoperative Blood Transfusion

Coenzyme Q-10 and Pulmonary Arterial Hypertension

Bilateral Paravertebral Blockade (T7-10) vs. Incisional Local Anesthetic Administration for Pediatric Patients

Administration Method of Cognitive Screening in Older Individuals With Hearing Loss

A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years.

PTGS1 Genetic Variation and Increased Risk for Persistent Pulmonary Hypertension of the Newborn

Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients

Effect of Lentils and Chickpeas on Gut Microbiome and Metabolic Health

A Study to Test the SENSE Device in Military-Age Patients With Traumatic Brain Injury

Alveolar Ridge Preservation With Putty Allograft vs. Putty Alloplast Graft

Osteopathic Manipulative Medicine in Pregnancy: Physiologic and Clinical Effects

Sternal Block With Liposomal Bupivacaine vs. Saline Prior to Incision in Cardiac Surgery

Pain with Differing Intraperitoneal Washes At the End of Laparoscopic Gynecologic Surgery